148 related articles for article (PubMed ID: 32943104)
21. Low-grade gastric adenomas/dysplasias: phenotypic expression, DNA ploidy pattern, and LOH at microsatellites linked to the APC gene.
Tanaka A; Takemura-Tsukashita S; Kushima R; Sugihara H; Fujiyama Y; Hattori T
Pathol Res Pract; 2008; 204(1):1-9. PubMed ID: 17964080
[TBL] [Abstract][Full Text] [Related]
22. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach.
Tamura G; Sakata K; Maesawa C; Suzuki Y; Terashima M; Satoh K; Sekiyama S; Suzuki A; Eda Y; Satodate R
Cancer Res; 1995 May; 55(9):1933-6. PubMed ID: 7728762
[TBL] [Abstract][Full Text] [Related]
24. Solid-type poorly differentiated adenocarcinoma of the stomach: clinicopathological and molecular characteristics and histogenesis.
Arai T; Matsuda Y; Aida J; Takubo K; Ishiwata T
Gastric Cancer; 2019 Mar; 22(2):314-322. PubMed ID: 30088163
[TBL] [Abstract][Full Text] [Related]
25. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
[TBL] [Abstract][Full Text] [Related]
26. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells.
Oue N; Sentani K; Sakamoto N; Uraoka N; Yasui W
Int J Clin Oncol; 2019 Jul; 24(7):771-778. PubMed ID: 30980196
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability in esophageal adenocarcinoma.
Evans SC; Gillis A; Geldenhuys L; Vaninetti NM; Malatjalian DA; Porter GA; Guernsey DL; Casson AG
Cancer Lett; 2004 Aug; 212(2):241-51. PubMed ID: 15279904
[TBL] [Abstract][Full Text] [Related]
28. How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53.
Yoshimura A; Sugihara H; Ling ZQ; Peng DF; Mukaisho K; Fujiyama Y; Hattori T
Pathobiology; 2006; 73(1):40-9. PubMed ID: 16785766
[TBL] [Abstract][Full Text] [Related]
29. Genetic differences stratified by PCR-based microsatellite analysis in gastric intramucosal neoplasia.
Sugai T; Sugimoto R; Habano W; Endoh M; Eizuka M; Tsuchida K; Yamamoto E; Kawasaki K; Yanai S; Matsumoto T; Suzuki H
Gastric Cancer; 2017 Mar; 20(2):286-296. PubMed ID: 27236438
[TBL] [Abstract][Full Text] [Related]
30. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
Virchows Arch; 2019 Mar; 474(3):315-324. PubMed ID: 30554333
[TBL] [Abstract][Full Text] [Related]
31. High frequency of microsatellite instability in intestinal-type gastric cancer in Korean patients.
Choe WH; Lee SY; Lee JH; Shim SG; Kim YH; Rhee PL; Rhee JC; Ki CS; Kim JW; Song SY; Kim JJ
Korean J Intern Med; 2005 Jun; 20(2):116-22. PubMed ID: 16134765
[TBL] [Abstract][Full Text] [Related]
32. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes.
Wu MS; Lee CW; Shun CT; Wang HP; Lee WJ; Chang MC; Sheu JC; Lin JT
Genes Chromosomes Cancer; 2000 Apr; 27(4):403-11. PubMed ID: 10719371
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
[TBL] [Abstract][Full Text] [Related]
34. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
35. Allelotype analysis of adenocarcinoma of the gastric cardia.
Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
Br J Cancer; 1997; 76(11):1455-65. PubMed ID: 9400942
[TBL] [Abstract][Full Text] [Related]
36. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
Tober JM; Halske C; Behrens HM; Krüger S; Röcken C
Hum Pathol; 2019 Dec; 94():98-109. PubMed ID: 31704366
[TBL] [Abstract][Full Text] [Related]
38. Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.
Barua RR; Uozaki H; Chong JM; Ushiku T; Hino R; Chang MS; Nagai H; Fukayama M
J Gastroenterol; 2006 Aug; 41(8):733-9. PubMed ID: 16988760
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the beneficial loci and prognostic implications of microsatellite instability in gastric carcinoma.
Kang JU; Koo SH
Mol Med Rep; 2011; 4(6):1175-81. PubMed ID: 21805035
[TBL] [Abstract][Full Text] [Related]
40. Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions.
van Dekken H; Alers JC; Riegman PH; Rosenberg C; Tilanus HW; Vissers K
Am J Pathol; 2001 Jun; 158(6):1961-7. PubMed ID: 11395372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
